Niche Pharmacogenomics Position iGenomeDx as a specialized pharmacogenomics and DNA-based infectious disease testing partner for hospitals and clinics seeking personalized medicine solutions, highlighting potential for expanded payer-supported testing programs.

Small but Ambitious Target low-to-mid volume healthcare facilities and regional networks where a 2-10 employee operation can offer nimble service, fast turnaround, and personalized account management that larger labs struggle to provide.

Minority-Owned Advantage Leverage recognition as Minority-Owned Small Business of the Year to open doors with hospital procurement teams favoring diverse supplier programs and to differentiate in vendor diversity metrics.

Growth through Collaboration Explore partnerships with regional hospital systems, academic medical centers, and community health networks to co-develop pharmacogenomics panels, infectious disease diagnostics, and value-based care initiatives.

Digital Enablement Emphasize cloud-based operations, secure data handling, and web-enabled ordering and results delivery to streamline workflows for clinicians, potentially integrating with existing hospital IT ecosystems.